Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
19-21 November, 2024
Not Confirmed
Not Confirmed
19-21 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
19-21 November, 2024
Industry Trade Show
Not Confirmed
19-21 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
18 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/943769/cns-pharmaceuticals-announces-abstract-accepted-for-poster-presentation-at-the-29th-annual-meeting-of-the-society-for-neuro-oncology-sno-2024
15 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/943295/cns-pharmaceuticals-reports-third-quarter-2024-financial-results
23 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/935062/cns-pharmaceuticals-announces-pricing-of-3-million-registered-direct-offering-of-common-stock-priced-at-the-market-under-nasdaq-rules
10 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/929679/cns-pharmaceuticals-participates-in-virtual-investor-kol-connect-segment
08 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/928550/cns-pharmaceuticals-to-participate-in-the-2024-healthcare-virtual-summit-presented-by-maxim-group-llc
12 Sep 2024
// ACCESSWIRE
https://www.accesswire.com/916740/cns-pharmaceuticals-regains-compliance-with-nasdaq-equity-requirement
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?